Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data

SARS-CoV-2 Vaccines and the Growing Threat of Viral Variants

(2021) John P. Moore et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients

(2021) Sharon Amit et al.   LANCET

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

(2021) Noa Dagan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine–elicited human sera

(2021) Alexander Muik et al.   SCIENCE

Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study

(2021) Eleftheria Vasileiou et al.   LANCET

Effectiveness of the Pfizer-BioNTech COVID-19 Vaccine Among Residents of Two Skilled Nursing Facilities Experiencing COVID-19 Outbreaks — Connecticut, December 2020–February 2021

(2021) Amadea Britton et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Reopening Society and the Need for Real-Time Assessment of COVID-19 at the Community Level

(2020) Frederick J. Angulo et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults

(2020) Mark J. Mulligan et al.   NATURE

Comprehensive Analyses of SARS-CoV-2 Transmission in a Public Health Virology Laboratory

(2020) Neta S. Zuckerman et al.   Viruses-Basel

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

(2020) Fernando P. Polack et al.   NEW ENGLAND JOURNAL OF MEDICINE

Further Evidence for Bias in Observational Studies of Influenza Vaccine Effectiveness: The 2009 Influenza A(H1N1) Pandemic

(2013) M. L. Jackson et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

"Herd Immunity": A Rough Guide

(2011) P. Fine et al.   CLINICAL INFECTIOUS DISEASES